Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
CEMIG Preferred Shares
CIG
$5.78B
| $13.2M | 0.01% |
8,878,464
-6,170,477
| -41% | -$8.67M |
|
1702
AXIS Capital
AXS
$7.25B
| $13.2M | 0.01% |
287,473
-60,428
| -17% | -$3M |
|
|
AONC
1703
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
| $13.2M | 0.01% |
1,363,722
+1,006,994
| +282% | +$9.76M |
|
1704
Pilgrim's Pride
PPC
$7.72B
| $13.2M | 0.01% |
454,853
-67,030
| -13% | -$1.68M |
|
1705
United Microelectronic
UMC
$49.2B
| $13.2M | 0.01% |
+1,153,343
| New | +$12.4M |
|
1706
State Street Energy Select Sector SPDR ETF
XLE
$40.8B
| $13.2M | 0.01% |
506,008
-3,754,976
| -88% | -$93M |
|
1707
Edison International
EIX
$28.8B
| $13.2M | 0.01% |
237,434
+105,988
| +81% | +$6.08M |
|
1708
Copart
CPRT
$30.9B
| $13.1M | 0.01% |
378,676
+347,844
| +1,128% | +$12.4M |
|
1709
Las Vegas Sands
LVS
$30.6B
| $13.1M | 0.01% |
358,708
-1,258,344
| -78% | -$54M |
|
|
SLAM
1710
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
| $13.1M | 0.01% |
1,346,398
+546,168
| +68% | +$5.3M |
|
1711
WSFS Financial
WSFS
$4.01B
| $13.1M | 0.01% |
255,649
+237,309
| +1,294% | +$10.7M |
|
1712
Gildan
GIL
$10.1B
| $13.1M | 0.01% |
+358,074
| New | +$13.2M |
|
1713
PUT
Avantor
AVTR
$9.75B
| $13.1M | 0.01% |
319,800
+79,800
| +33% | +$3.12M |
|
|
FSRX
1714
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
| $13.1M | 0.01% |
1,341,997
+323,344
| +32% | +$3.14M |
|
1715
FTI Consulting
FCN
$4.19B
| $13M | 0.01% |
96,858
+27,184
| +39% | +$3.77M |
|
|
BSN
1716
DELISTED
Broadstone Acquisition Corp.
BSN
| $13M | 0.01% |
1,307,754
+142,403
| +12% | +$1.41M |
|
|
TCVA
1717
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
| $13M | 0.01% |
1,327,169
-5,904
| -0.4% | -$58.3K |
|
1718
STAG Industrial
STAG
$7.15B
| $13M | 0.01% |
331,336
-422,029
| -56% | -$17.2M |
|
|
HLGN
1719
DELISTED
Heliogen, Inc.
HLGN
| $13M | 0.01% |
37,366
+29,147
| +355% | +$10.1M |
|
1720
Amdocs
DOX
$6.51B
| $13M | 0.01% |
171,440
-33,361
| -16% | -$2.58M |
|
1721
Mercury Systems
MRCY
$5.28B
| $13M | 0.01% |
273,233
+34,362
| +14% | +$1.91M |
|
1722
UMB Financial
UMBF
$10.9B
| $13M | 0.01% |
133,961
+119,481
| +825% | +$10.9M |
|
1723
Ryman Hospitality Properties
RHP
$9.17B
| $12.9M | 0.01% |
154,705
-166,950
| -52% | -$13.3M |
|
1724
Manchester United
MANU
$4.12B
| $12.9M | 0.01% |
667,368
+574,017
| +615% | +$9.66M |
|
1725
Payoneer
PAYO
$2.41B
| $12.9M | 0.01% |
1,511,021
-6,383,333
| -81% | -$62M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.